New and Updated Clinical Chikungunya Vaccine Trials

A Phase 2 Open-label Study to Assess the Safety and Immunogenicity of an Alum-adjuvanted Chikungunya Virus-like Particle Vaccine (PXVX0317) in Prior Recipients of Other Alphavirus Vaccines

Jun 20, 2019 | 18:00 pm

Condition: ChikungunyaIntervention: Biological: ChikungunyaSponsors: Emergent BioSolutions; Walter Reed Army Institute of Research (WRAIR)Not yet recruiting

Chikungunya Vaccine Study in Previously Exposed Adults

Jan 17, 2019 | 18:00 pm

Condition: Chikungunya Virus InfectionInterventions: Biological: MV-CHIK; Other: PlaceboSponsors: Themis Bioscience GmbH; Walter Reed Army Institute of Research (WRAIR)Recruiting

Resistance Exercise Program on the Functionality of Individuals With Chikungunya Fever

Oct 11, 2018 | 18:00 pm

Condition: Chikungunya FeverIntervention: Other: Resistance exerciseSponsor: Universidade Federal de PernambucoActive, not recruiting

Genetic Factors and Immunological Determinism of Persistent Consequences of Chikungunya

Oct 1, 2018 | 18:00 pm

Condition: Chikungunya FeverInterventions: Other: Quality of life survey; Genetic: Saliva collection; Genetic: Blood collectionSponsors: Centre Hospitalier Universitaire de la Réunion; Conservatoire national des Arts et MétiersRecruiting

Trial of a Chikungunya Vaccine, PXVX0317 CHIKV-VLP, in Healthy Adults

Mar 30, 2018 | 18:00 pm

Condition: Chikungunya Virus InfectionInterventions: Biological: CHIKV VLP/unadjuvanted; Biological: CHIKV VLP/adjuvanted; Biological: PlaceboSponsor: Emergent BioSolutionsActive, not recruiting

Study to Assess the Safety and Immunogenicity of a Chikungunya Virus Vaccine Candidate (VLA1553) in Healthy Volunteers

Dec 26, 2017 | 18:00 pm

Condition: ChikungunyaIntervention: Biological: VLA1553Sponsor: Valneva Austria GmbHCompleted

Study of a Live Attenuated Chikungunya Vaccine in a Previously Epidemic Area

Apr 4, 2017 | 18:00 pm

Condition: ChikungunyaInterventions: Biological: MV-CHIK; Biological: MMR-vaccineSponsors: Themis Bioscience GmbH; Walter Reed Army Institute of Research (WRAIR)Completed

Effects of Auriculotherapy on Pain and Functional Capacity of Individuals With Chikungunya Fever

Mar 27, 2017 | 18:00 pm

Condition: Chikungunya FeverInterventions: Procedure: True auriculotherapy with seeds; Procedure: Placebo Auriculotherapy with seedsSponsor: Universidade Federal do CearaCompleted

Efficacy of Starting Methotrexate Early in Chikungunya Arthritis

Feb 23, 2017 | 18:00 pm

Condition: Early Chikungunya ArthritisInterventions: Drug: Methotrexate; Drug: NSAID; Drug: SteroidsSponsor: Postgraduate Institute of Medical Education and ResearchCompleted

Impact of the Chikungunya Outbreak in Reunion Island on the Quality of Life After 10 Years

Sep 15, 2016 | 18:00 pm

Conditions: Chikungunya Fever; Quality of LifeIntervention: Sponsor: Centre Hospitalier Universitaire de la RéunionCompleted

Phase II Study to Evaluate Safety and Immunogenicity of a Chikungunya Vaccine

Aug 10, 2016 | 18:00 pm

Condition: Chikungunya Virus InfectionInterventions: Biological: MV-CHIK low dose; Biological: MV-CHIK high dose; Biological: Priorix®; Biological: physiological saline solutionSponsor: Themis Bioscience GmbHCompleted

The Evaluation of Potential Zika, Chikungunya, and Dengue Infections in Mexico

Jul 13, 2016 | 18:00 pm

Conditions: Zika Virus Disease (Disorder); Dengue; ChikungunyaIntervention: Sponsors: Mexican Emerging Infectious Diseases Clinical Research Network; Secretaria de Salud, Mexico; National Institute of Allergy and Infectious Diseases (NIAID)Completed

RT-PCR on Urine Samples: Added Value for the Diagnosis of Chikungunya Virus Infection

Mar 22, 2016 | 17:00 pm

Condition: Chikungunya FeverIntervention: Sponsor: Institute of Tropical Medicine, BelgiumSuspended

Trial for Safety and Immunogenicity of a Chikungunya Vaccine, VRC-CHKVLP059-00-VP, in Healthy Adults

Sep 29, 2015 | 18:00 pm

Condition: Chikungunya Virus InfectionInterventions: Biological: VRC-CHKVLP059-00-VP; Other: VRC-PBSPLA043-00-VPSponsors: National Institute of Allergy and Infectious Diseases (NIAID); The Emmes Company, LLC; Leidos; FHI 360Completed

Seroprevalence of Chikungunya at the End of the First Chikungunya Outbreak in the French Antilles Within a Sample of Patients Treated for a HIV Infection

Sep 17, 2015 | 18:00 pm

Conditions: HIV Infections; Chikungunya Virus InfectionIntervention: Other: Biological sample collectionSponsor: University Hospital Center of MartiniqueCompleted

Chikungunya Arthritis in the Americas

Jun 4, 2015 | 18:00 pm

Conditions: Chikungunya; ArthritisInterventions: Procedure: Venipuncture for blood draw; Procedure: Arthrocentesis for synovial fluid drawSponsors: George Washington University; Global Disease Research; United States Army Medical Research Institute of Infectious Diseases; Broad Institute; Allied Research SocietyCompleted

Study of the Prognostic Value of Musculoskeletal Ultrasound in Adults With Chikungunya

Nov 2, 2014 | 17:00 pm

Condition: Infected by Chikungunya VirusIntervention: Other: SF36 (QQoL)Sponsor: University Hospital Center of MartiniqueUnknown status

The Pilot Study of Chikungunya Virus Infections in Southern Taiwan

Jun 25, 2014 | 18:00 pm

Condition: Chikungunya FeverIntervention: Sponsor: Kaohsiung Medical University Chung-Ho Memorial HospitalCompleted

Chikungunya Virus Vaccine Trial in Healthy Adults

Dec 9, 2011 | 18:00 pm

Conditions: Viral Vaccines; Chikungunya Fever; Chikungunya Virus InfectionIntervention: Biological: VRC-CHKVLP059-00-VPSponsor: National Institute of Allergy and Infectious Diseases (NIAID)Completed

CuraChik : A Trial of the Efficacy and Safety of Chloroquine as Therapeutic Treatment of Chikungunya Disease

Oct 23, 2006 | 18:00 pm

Condition: Chikungunya VirusIntervention: Drug: ChloroquineSponsor: Assistance Publique Hopitaux De MarseilleTerminated

Main Menu

Login Form

Related Links